logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (vi) New inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates18.646.161.166.661.250.347.827.63123162
Cocaine1.94.06.96.28.09.72.20.731035
Stimulants18.822.215.09.19.710.36.55.2114364
Hypnotics and sedatives3.12.53.25.411.114.528.349.3326114
Hallucinogens0.20.30.10.00.00.00.00.0111
Volatile substances11.92.20.50.70.30.00.00.018613
Cannabis 44.621.812.09.17.610.37.69.01326105
Other substances 0.91.01.43.02.14.87.68.210683
Total9262881146959528914592376531577

Notes:

 : indicates data not available 

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV, AT, RO, SK, FI, SE, HR, TR 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2008 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009